STE RSI

What is STE?

STERIS has come a long way since its 1987 founding in Ohio as Innovative Medical Technologies. Rebranding to STERIS in 1992, the company has grown from a small sterilization startup into a global powerhouse in infection prevention. Its history is marked by strategic consolidation, notably the 2015 merger with Synergy Health, which shifted its domicile to the UK, and the massive acquisition of Cantel Medical in 2021.

The core business model is built on a razor-and-blade strategy. While they sell high-end capital equipment like surgical tables and V-PRO low-temperature sterilizers, the real money comes from high-margin recurring revenue. This includes consumables, maintenance services, and outsourced sterilization for medical device manufacturers. Their reach spans four main segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental.

In the Healthcare segment, they are the backbone of the operating room, providing everything from surgical lighting to endoscope reprocessing systems. The Applied Sterilization Technologies (AST) segment is particularly vital, offering contract sterilization services using gamma and E-beam technologies that medical device makers rely on to ensure product safety before they hit the market.

Financially, STERIS is a steady performer with a history of consistent dividend growth and robust free cash flow. They have successfully integrated recent acquisitions, which has bolstered their competitive moat in the endoscopy and water purification markets. Despite some macroeconomic headwinds, their balance sheet remains healthy with a clear path toward margin expansion.

Looking toward 2026, the strategic outlook is focused on the STERIS Business System to drive operational efficiency. We can expect them to capitalize on the rising volume of elective surgeries and the increasing complexity of medical devices requiring specialized cleaning. Management is also prioritizing debt reduction and expanding their AST capacity globally to meet the soaring demand from the pharmaceutical and biotech sectors. The company is positioning itself as an indispensable partner in a world that is increasingly focused on high hygiene and safety standards.

What is RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and magnitude of price changes. Developed by J. Welles Wilder, RSI ranges from 0 to 100 and helps traders identify overbought or oversold conditions in an asset.

For STE, monitoring the RSI provides valuable insights into potential trend reversals and entry/exit points. When the RSI drops below 30, STERIS plc is typically considered oversold, suggesting the asset may be undervalued. Conversely, an RSI above 70 indicates overbought conditions.

Understanding STE RSI Signals

• Oversold (RSI below 30): When STE RSI falls below 30, it suggests the asset may have been sold off excessively and could be due for a bounce. This is often viewed as a potential buying opportunity, though it's important to consider other factors and not rely solely on RSI.
• Overbought (RSI above 70): An RSI above 70 indicates STE may be overbought, potentially signaling a pullback or consolidation phase. Traders often use this as a signal to take profits or wait for better entry points.
• Divergences: When STE price makes new highs or lows but RSI doesn't confirm these moves, it can signal weakening momentum and a possible trend reversal.

Daily vs Weekly RSI for STE

This page displays both daily and weekly RSI for STE. The daily RSI responds quickly to short-term price movements, making it useful for day traders and swing traders. The weekly RSI provides a broader perspective on momentum trends, helping longer-term investors identify major oversold or overbought conditions.

By analyzing both timeframes together, you can better understand STERIS plc's momentum at multiple levels and make more informed trading decisions.

Historical RSI Oversold Analysis

Above, we track historical instances when STE RSI dropped below 30 (oversold territory). Reviewing these past oversold levels helps identify patterns and understand how STERIS plc has historically responded to oversold conditions. Many traders use these historical reference points to gauge potential support levels and timing for entry positions.